In pancreatic ductal adenocarcinoma (PDAC), R848 was shown to primarily act on stromal cell TLR7 rather than tumor cells and induce CD8 T-cell infiltration, activation and cytotoxicity, and decrease Treg cells [69]. This evidence concerns the gene TLR7 and neoplasm.